Fish Oils: Clinical Trials

12 trials of Fish Oils, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 12

Follow Fish Oils: new trials by email Literature Review of Fish Oils trials Research Report on Fish Oils

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Can Omega-3 Improve Heart Rate Variability Measurement?
Omega-3 - Individuality
Phase 4CompletedVachira Phuket Hospital1002016-04-012016-11-01
The Effects of n-3 LCPUFAs in Patients With Colorectal Cancer
Fish Oil, Placebo - Cancer Cachexia, Side Effects
Phase 4CompletedUniversity of Copenhagen502015-04-012021-01-07
Supplementation in Adolescent Girls With Endometriosis
Vitamin D3, Fish Oil, Placebo - Endometriosis
Phase 4CompletedBoston Children's Hospital692014-09-012016-12-01
Omega-3 Supplementation to ADHD Medication in Children
Omega-3 Fatty Acid, ADHD Medication - Attention Deficit Hyperactivity Disorder, Deficient Emotional Self-Regulation
Phase 4CompletedMassachusetts General Hospital212014-07-012017-06-29
Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease
Omegaven 10%, Intralipid 20% - Crohn Disease
Phase 4CompletedRadboud University Medical Center62014-01-012015-11-10
Efficacy of Fish Oil in Multiple Sclerosis
Fish Oil, Placebo - Relapsing- Remitting Multiple Sclerosis
Phase 4CompletedCoordinación de Investigación en Salud, Mexico502010-05-012013-05-22
Effects of Omega-3 Fatty Acids on the Human Gene Expression
Fish oil, Placebo (corn oil) - Hyperlipidemia, Healthy
Phase 4CompletedGottfried Wilhelm Leibniz Universität Hannover402010-03-012011-12-19
Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE)
Neptune Krill Oil, Fish Oil, Placebo (soy oil) - Early Onset Alzheimer Disease
Phase 4CompletedNeuroBioPharm Inc.1752009-05-012011-10-03
Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation
Fish oil, Placebo - Atrial Fibrillation
Phase 4CompletedVanderbilt University1902007-11-012014-12-03
Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation.
Fish oil - Atrial Fibrillation
Phase 4CompletedMelbourne Health802003-12-012013-05-30
Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia
Fish oil - Atrial Fibrillation, Atrial Flutter
Phase 4CompletedMelbourne Health1002003-09-012015-05-12
Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion
Fish oil - Atrial Fibrillation
Phase 4CompletedMelbourne Health2002003-01-012015-05-05

Conditions studied

Atrial Fibrillation (4)  ·  Alzheimer Disease (1)  ·  Atrial Flutter (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Coronary Disease (1)  ·  Crohn Disease (1)  ·  Endometriosis (1)  ·  Hyperlipidemias (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Neoplasms (1)  ·  Pain (1)

Sponsors

Melbourne Health (3)  ·  Boston Children's Hospital (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Gottfried Wilhelm Leibniz Universität Hannover (1)  ·  Massachusetts General Hospital (1)  ·  NeuroBioPharm Inc. (1)  ·  Radboud University Medical Center (1)  ·  University of Copenhagen (1)  ·  Vachira Phuket Hospital (1)  ·  Vanderbilt University (1)

Countries

Australia (3)  ·  United States (3)  ·  Canada (1)  ·  Denmark (1)  ·  Germany (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Thailand (1)

Top investigators

Paul Sparks (2)  ·  Andreas Hahn, Prof. (1)  ·  Charles M. Stein (1)  ·  D de Jong, MD, PhD (1)  ·  F. Hoentjen, MD, PhD (1)  ·  G. Wanten, MD, PhD (1)  ·  Genaro G Ortiz, phD (1)  ·  Jens R Andersen (1)  ·  Jessada Chungpaibulpatana, MD. (1)  ·  P. Calder, MD, PhD (1)  ·  Paul Sparks, MBBS, PhD. FRACP (1)  ·  Stacey A Missmer, ScD (1)  ·  Timothy E. Wilens, MD (1)

Results publications

PMID 21232631, PMID 22621246, PMID 22929118, PMID 23241455, PMID 23890856, PMID 25465932, PMID 32453393

NIH funding

R01HL087254 (1)